Answers are grounded in this paper and cite their sources.
The main objective of the work is the application of experimental design and some simple tests (t-ratios) in the evaluation of bioequivalence of two treatments. It is performed the assessment of the effectiveness of different treatments administered to two groups of patients: the control group and the test group. The comparison of the control group that received the reference medication with the control group test, which received the drug under study, using a crossover experimental design. It was performed an analysis using t-ratios and considering and inter-subject variability formulation of the probabilistic model, where the specification of tests for detection of carryover and period effects were considered. The application to a practical case consisted in the validation of the hypothesis of the proposed model took place, where the effects carryover and period were not significant when considering usual levels of significance. About the treatments, we could conclude that there was statistical significance to affirm that the studied pharmaceuticals were not bioequivalent.
No takes yet. Share an insight, caveat, or question.
Teodoro et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: